Ligand Pharmaceuticals Inc (NASDAQ:LGND)

238.05
BATS BZX Real-Time Price
As of 11:44am ET
 -9.93 / -4.00%
Today’s Change
123.11
Today|||52-Week Range
255.38
+73.85%
Year-to-Date

Today’s Trading

Previous close247.98
Today’s open245.11
Day’s range236.94 - 245.11
Volume6,118
Average volume (3 months)336,962
Market cap$5.2B
Data as of 11:44am ET, 08/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+86.25%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+29.48%
P/E ratio49.1
Price/Sales22.79
Price/Book13.09

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-2.05-1.51%
PBHPrestige Consumer He...-0.28-0.72%
MDCOMedicines Co-0.59-1.48%
ICPTIntercept Pharmaceut...+0.54+0.52%
Data as of 11:44am ET, 08/20/2018

Financials

Next reporting dateOctober 31, 2018
EPS forecast (this quarter)$1.08
Annual revenue (last year)$141.1M
Annual profit (last year)$12.6M
Net profit margin8.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts